J u m p t o c o n t e n t
M a i n m e n u
M a i n m e n u
N a v i g a t i o n
● M a i n p a g e
● C o n t e n t s
● C u r r e n t e v e n t s
● R a n d o m a r t i c l e
● A b o u t W i k i p e d i a
● C o n t a c t u s
● D o n a t e
C o n t r i b u t e
● H e l p
● L e a r n t o e d i t
● C o m m u n i t y p o r t a l
● R e c e n t c h a n g e s
● U p l o a d f i l e
S e a r c h
Search
A p p e a r a n c e
● C r e a t e a c c o u n t
● L o g i n
P e r s o n a l t o o l s
● C r e a t e a c c o u n t
● L o g i n
P a g e s f o r l o g g e d o u t e d i t o r s l e a r n m o r e
● C o n t r i b u t i o n s
● T a l k
( T o p )
1
A c t i v i t i e s
2
R e f e r e n c e s
T o g g l e t h e t a b l e o f c o n t e n t s
I n s t i t u t e f o r S a f e M e d i c a t i o n P r a c t i c e s
A d d l a n g u a g e s
A d d l i n k s
● A r t i c l e
● T a l k
E n g l i s h
● R e a d
● E d i t
● V i e w h i s t o r y
T o o l s
T o o l s
A c t i o n s
● R e a d
● E d i t
● V i e w h i s t o r y
G e n e r a l
● W h a t l i n k s h e r e
● R e l a t e d c h a n g e s
● U p l o a d f i l e
● S p e c i a l p a g e s
● P e r m a n e n t l i n k
● P a g e i n f o r m a t i o n
● C i t e t h i s p a g e
● G e t s h o r t e n e d U R L
● D o w n l o a d Q R c o d e
● W i k i d a t a i t e m
P r i n t / e x p o r t
● D o w n l o a d a s P D F
● P r i n t a b l e v e r s i o n
A p p e a r a n c e
F r o m W i k i p e d i a , t h e f r e e e n c y c l o p e d i a
The Institute for Safe Medication Practices (ISMP) is an American 501(c )(3 ) organization focusing on the prevention of medication errors and promoting safe medication practices.[1] It is affiliated with ECRI .[2]
Activities [ edit ]
Among others, ISMP maintains and disseminates a list of "do not crush" medications,[3] as well as clinical best practices.[4] The ISMP's Medication Safety Self-Assessment tool has been used in surveys of medication safety in hospitals in the United States and elsewhere.[5] [6] [7] [8]
The ISMP frequently investigates and reports on medication errors that have occurred in practice. These investigations are often published in the peer-reviewed journal Hospital Pharmacy .[9] [10] [11]
References [ edit ]
^ Cohen, Michael R. (July 2007). " "Do Not Crush" list" . Nursing2021 . 37 (7 ): 12. doi :10.1097/01.NURSE.0000279404.54880.3a . ISSN 0360-4039 .
^ "ISMP Publishes 2020-2021 Consensus-Based Medication Safety Best Practices for Hospitals" . Institute For Safe Medication Practices . 27 February 2020. Retrieved 2021-06-30 .
^ Lesar, Timothy; Mattis, Arnold; Anderson, Ernest; Avery, Jean; Fields, John; Gregoire, Jill; Vaida, Allen; VHA New England Medication Error Prevention Initiative Collaborative (2003-05-01). "Using the ISMP Medication Safety Self-Assessment™ to Improve Medication Use Processes" . The Joint Commission Journal on Quality and Safety . 29 (5 ): 211–226. doi :10.1016/S1549-3741(03 )29026-2 . ISSN 1549-3741 . PMID 12751302 – via Elsevier Science Direct .
^ Vaida, Allen J.; Lamis, Rebecca L.; Smetzer, Judy L.; Kenward, Kevin; Cohen, Michael R. (2014-02-01). "Assessing the State of Safe Medication Practices Using the ISMP Medication Safety Self Assessment® for Hospitals: 2000 and 2011" . The Joint Commission Journal on Quality and Patient Safety . 40 (2 ): 51–AP3. doi :10.1016/S1553-7250(14 )40007-2 . ISSN 1553-7250 . PMID 24716328 .
^ Greenall, Julie; Shastay, Ann; Vaida, Allen J; U, David; Johnson, Philip E; O’Leary, Joe; Chambers, Carole (2015-02-01). "Establishing an international baseline for medication safety in oncology: Findings from the 2012 ISMP International Medication Safety Self Assessment® for Oncology" . Journal of Oncology Pharmacy Practice . 21 (1 ): 26–35. doi :10.1177/1078155214556522 . ISSN 1078-1552 . PMID 25361598 . S2CID 36967892 .
^ McCarthy, Kaitlyn R.; Christakos, Eugenia; Kurzatkowski, Amy; Gernant, Stephanie A. (2021-07-01). "Characterizing perceptions of an abbreviated ISMP Medication Safety Self Assessment for community pharmacies" . Journal of the American Pharmacists Association . 61 (4 ): S105–S117. doi :10.1016/j.japh.2021.02.013 . ISSN 1544-3191 . PMID 33812781 . S2CID 233029198 .
^ Mancano, Michael A.; Esordi, Morgan V.; Patel, Darshil D.; Milenki, Kristen J. (2019-04-01). "ISMP Adverse Drug Reactions: Longitudinal Thumbnail Fissures Due to Erlotinib Priapism Associated With the Use of ExtenZe Blindness From a Nevirapine-Based HAART Regimen Hyperprolactinemia and Galactorrhea Due to Aripiprazole Trypophobia Associated With Gabapentin Coadministered Linezolid and Methadone Cause Serotonin Syndrome" . Hospital Pharmacy . 54 (2 ): 88–92. doi :10.1177/0018578718824449 . ISSN 0018-5787 . PMC 6431722 . PMID 30923400 .
^ Mancano, Michael A. (2018-02-01). "ISMP Adverse Drug Reactions: Influenza Vaccine–Induced Stevens-Johnson Syndrome; Vilazodone-Induced Nightmares; Dabigatran-Induced Pustular Eruptions; Neurotoxic and Cardiotoxic Symptoms After Cannabis Concentrate Exposure; Rosuvastatin-Induced Skin Eruption" . Hospital Pharmacy . 53 (1 ): 15–17. doi :10.1177/0018578717739727 . ISSN 0018-5787 . PMC 5805017 . PMID 29434381 .
^ Mancano, Michael A.; Lapin, Jonathan; Paik, Andrew (2019-08-01). "ISMP Adverse Drug Reactions: Pheochromocytoma Crisis Induced by Metoclopramide Baclofen Dependence Following High-Dose Therapy Fatal Cardiotoxicity Following High-Dose Cyclophosphamide Acute Anterograde Amnestic Syndrome Induced by Fentanyl Ivermectin-Induced Toxic Epidermal Necrolysis Pembrolizumab-Induced Type 1 Diabetes" . Hospital Pharmacy . 54 (4 ): 241–245. doi :10.1177/0018578719828860 . ISSN 0018-5787 . PMC 6628555 . PMID 31320773 .
t
e
R e t r i e v e d f r o m " https://en.wikipedia.org/w/index.php?title=Institute_for_Safe_Medication_Practices&oldid=1182946757 "
C a t e g o r i e s :
● P h a r m a c o l o g y
● D r u g s a f e t y
● P a t i e n t s a f e t y
● P h a r m a c o l o g y s t u b s
H i d d e n c a t e g o r i e s :
● A r t i c l e s w i t h a p r o m o t i o n a l t o n e f r o m A u g u s t 2 0 2 1
● A l l a r t i c l e s w i t h a p r o m o t i o n a l t o n e
● W i k i p e d i a a r t i c l e s w i t h s t y l e i s s u e s f r o m A u g u s t 2 0 2 1
● A l l a r t i c l e s w i t h s t y l e i s s u e s
● A r t i c l e s w i t h I S N I i d e n t i f i e r s
● A r t i c l e s w i t h V I A F i d e n t i f i e r s
● A r t i c l e s w i t h L C C N i d e n t i f i e r s
● A l l s t u b a r t i c l e s
● T h i s p a g e w a s l a s t e d i t e d o n 1 N o v e m b e r 2 0 2 3 , a t 1 0 : 4 4 ( U T C ) .
● T e x t i s a v a i l a b l e u n d e r t h e C r e a t i v e C o m m o n s A t t r i b u t i o n - S h a r e A l i k e L i c e n s e 4 . 0 ;
a d d i t i o n a l t e r m s m a y a p p l y . B y u s i n g t h i s s i t e , y o u a g r e e t o t h e T e r m s o f U s e a n d P r i v a c y P o l i c y . W i k i p e d i a ® i s a r e g i s t e r e d t r a d e m a r k o f t h e W i k i m e d i a F o u n d a t i o n , I n c . , a n o n - p r o f i t o r g a n i z a t i o n .
● P r i v a c y p o l i c y
● A b o u t W i k i p e d i a
● D i s c l a i m e r s
● C o n t a c t W i k i p e d i a
● C o d e o f C o n d u c t
● D e v e l o p e r s
● S t a t i s t i c s
● C o o k i e s t a t e m e n t
● M o b i l e v i e w